1. Impact of cathepsin D activity and C224T polymorphism (rs17571) on chronic obstructive pulmonary disease: correlations with oxidative and inflammatory markers
    Sarra Bchir et al, 2021, Clinical and Experimental Medicine CrossRef
  2. Identification and structure-activity relationship studies of small molecule inhibitors of the human cathepsin D
    Sandeep Goyal et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
  3. Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells
    Seung Un Seo et al, 2022, Cell Death & Disease CrossRef
  4. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
    Yuek Ling Chai et al, 2019, Brain Pathology CrossRef
  5. Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson’s Disease
    Ping Gan et al, 2020, Frontiers in Pharmacology CrossRef
  6. bFGF promotes neurological recovery from neonatal hypoxic–ischemic encephalopathy by IL‐1β signaling pathway‐mediated axon regeneration
    Zheng Ma et al, 2020, Brain and Behavior CrossRef
  7. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation‐mediated neurotoxicity through inhibition of NF‐κB signalling pathway in Parkinson's disease model
    Ping Gan et al, 2019, Clinical and Experimental Pharmacology and Physiology CrossRef
  8. Impact of astrocyte and lymphocyte interactions on the blood-brain barrier in multiple sclerosis
    X.-B. Yan et al, 2019, Revue Neurologique CrossRef
  9. Lung epithelial response to cigarette smoke and modulation by the nicotinic alpha 7 receptor
    Lorise C. Gahring et al, 2017, PLOS ONE CrossRef
  10. Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review
    Bruna Martins et al, 2022, Marine Drugs CrossRef
  11. Thromboxane A2 receptor antagonist SQ29548 attenuates SH‑SY5Y neuroblastoma cell impairments induced by oxidative stress
    Gaoyu Cai et al, 2018, International Journal of Molecular Medicine CrossRef
  12. Discovery of Repurposable Drugs in the Combination Therapy of Breast Cancer: A Virtual Drug Screening Study
    Ebru KIRMIZIAY et al, 2024, Turkish Computational and Theoretical Chemistry CrossRef
  13. NIR-excited superoxide radical procreators to eradicate tumors by targeting the lyso-membrane
    Bhaskar Gurram et al, 2019, Journal of Materials Chemistry B CrossRef
  14. Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents
    Melisa Bunderson-Schelvan et al, 2017, Journal of Toxicology and Environmental Health, Part B CrossRef
  15. Cathepsin D knockdown regulates biological behaviors of granulosa cells and affects litter size traits in goats
    Zhinan Zhou et al, 2021, Journal of Zhejiang University-SCIENCE B CrossRef
  16. Activation of TNFR1 and TLR4 following oxygen glucose deprivation promotes mitochondrial fission in C6 astroglial cells
    Avishek Halder et al, 2020, Cellular Signalling CrossRef